Cargando…
Optimizing expression of Nanobody® molecules in Pichia pastoris through co-expression of auxiliary proteins under methanol and methanol-free conditions
BACKGROUND: Ablynx NV, a subsidiary of Sanofi, has a long-standing focus on the development of Nanobody® molecules as biopharmaceuticals (Nanobody® is a registered trademark of Ablynx NV). Nanobody molecules are single variable domains, and they have been met with great success part due to their fav...
Autores principales: | De Groeve, Manu, Laukens, Bram, Schotte, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362571/ https://www.ncbi.nlm.nih.gov/pubmed/37481525 http://dx.doi.org/10.1186/s12934-023-02132-z |
Ejemplares similares
-
Pichia pastoris Mut(S) strains are prone to misincorporation of O-methyl-l-homoserine at methionine residues when methanol is used as the sole carbon source
por: Schotte, Peter, et al.
Publicado: (2016) -
A novel methanol-free Pichia pastoris system for recombinant protein expression
por: Shen, Wei, et al.
Publicado: (2016) -
Scalable methanol-free production of recombinant glucuronoyl esterase in Pichia pastoris
por: Conacher, C. G., et al.
Publicado: (2019) -
Recombinant protein expression in Pichia pastoris strains with an engineered methanol utilization pathway
por: Krainer, Florian W, et al.
Publicado: (2012) -
Engineering the expression system for Komagataella phaffii (Pichia pastoris): an attempt to develop a methanol-free expression system
por: Takagi, Shinobu, et al.
Publicado: (2019)